Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR-3355 (levofloxacin) injection in acute bacterial prostatitis or acute epididymitis
jRCT2080221853Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of levofloxacin in Acute Prostatitis and acute epididymitis, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
levofloxacin
03
Conditions
Acute Prostatitisacute epididymitis
Beyond the preview
Go deeper on jRCT2080221853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221853.